Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen iCarbonX Peptide Technology is a specialized subsidiary of iCarbonX, focusing on the intersection of peptide chemistry, immunology, and big data. The company utilizes a proprietary high-density peptide microarray platform to perform comprehensive immune profiling of individuals. This technology allows for the identification of unique immunosignatures that can be used for early disease detection, monitoring treatment response, and personalized health management. iCarbonX Peptide plays a critical role in the parent company's Digital Life Alliance by providing the molecular data necessary to map the human immune system at scale. Their services include diagnostic kit development and research collaborations for biomarker discovery in oncology and infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 深圳碳云智肽.